96981 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Hormones
Sub-classes:MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THEREOF FOR THE TREATMENT OF DISEASES
#2AMYLIN ANALOGUES
#3NOVEL IRISIN PEPTIDES AND METHODS OF USE THEREOF
#4CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS
#5MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERINE ONCOPROTECTION, AND OVARIAN RESERVE AND UTERINE PRESERVATION
#6PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#7PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#8INCRETIN ANALOGS AND USES THEREOF
#9Salmonella vectored therapies for treatment of cancer
#10HUMAN AMYLIN ANALOG, AND DERIVATIVE THEREOF AND USE THEREOF
#11BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS
#12GLP-1 Analog and Use Thereof in Treatment of GLP-1 Related Diseases
#13COMPOSITIONS AND METHODS
#14POLYPEPTIDE COMBINATIONS AND USES THEREOF
#15A GIP/GLP1 FOR USE IN THERAPY
#16PHASE TRANSITION ADJUSTING ELEMENT AND USE THEREOF
#17SOLUBLE NPY2 RECEPTOR AGONISTS
#18TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#19CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY
#20Soluble GLP1/GIP/NPY2 Receptor Triple Agonists
#21ARTIFICIAL PROTEIN AND USES THEREOF
#22AMYLIN RECEPTOR (hAMY3R) AGONISTS WITH IMPROVED CHEMICAL STABILITY
#23CONJUGATED HEPCIDIN MIMETICS
#24HEPCIDIN ANALOGUES AND USES THEREOF
#25MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF
#26PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#27TREATMENT METHOD USING MAZDUTIDE
#28KLOTHO DERIVATIVES WITH MODIFIED STRUCTURE
#29GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS
#30POLYPEPTIDES AND USES THEREOF
#31CONJUGATED HEPCIDIN MIMETICS
#32DUAL FUNCTION PROTEINS COMPRISING FGF21 MUTANT PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#33MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#34BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF
#35Enhanced Immunogenicity For GPI-anchored Antigens
#36CONJUGATED HEPCIDIN MIMETICS
#37METHOD OF TREATING DISEASE OR DISORDER USING COMPOSITIONS COMPRISING PHARMACEUTICALLY ACCEPTABLE SALTS OF AMYLIN ANALOGS
#38PEPTIDE ANALOGS
#39FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES
#40COMPOSITIONS COMPRISING THERAPEUTIC PROTEINS OR PEPTIDES, AND USES THEREOF
#41HAM15 52 ANALOGUES WITH IMPROVED AMYLIN RECEPTOR (HAMY3R) POTENCY
#42USE OF KININ OR DERIVATIVE THEREOF IN TREATING VCI, PSCI, OR CSVD
#43SATIATION PEPTIDE ADMINISTRATION
#44ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO
#45LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE
#46AMYLIN ANALOGUES
#47PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#48NOVEL PEPTIDE DERIVATIVE DERIVED FROM ADIPONECTIN AND USE THEREOF
#49COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEOPATHIES
#50IMMUNOGLOBULINS AND USES THEREOF
#51CHIMERIC ADIPONECTIN POLYPEPTIDES, EXTRACELLULAR VESICLE COMPRISING THE SAME, AND USES THEREOF
#52LONG-ACTING AMYLIN RECEPTOR AGONISTS AND USES THEREOF
#53SELF-REPLICATING RNA AND USES THEREOF
#54HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
#55HUMAN AMYLIN ANALOG POLYPEPTIDES AND METHODS OF USE
#56PEPTIDE IMMUNOGENS TARGETING ISLET AMYLOID POLYPEPTIDE (IAPP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF DISORDERS RELATED TO AGGREGATED IAPP
#57PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF
#58CELL-FREE METHODS AND COMPOSITIONS COMPRISING TAGLESS THERAPEUTIC HORMONES
#59APELIN RECEPTOR AGONISTS AND USES THEREOF
#60METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS
#61GENETICALLY MODIFIED PROBIOTICS FOR ORAL DELIVERY OF RENIN-ANGIOTENSIN RELATED THERAPEUTIC PROTEINS AND PEPTIDES
#62IONIC LIQUID COMPOSITIONS
#63IONIC LIQUID COMPOSITIONS
#64Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof
#65ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#66Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof
#67CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS
#68Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof
#69FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES
#70CONJUGATED HEPCIDIN MIMETICS
#71Fusion proteins for the treatment of cardiometabolic diseases
#72COMPOSITIONS AND METHODS FOR PREVENTING OR DELAYING PUBERTY IN PREPUBESCENT NON-HUMAN ANIMALS AND HUMANS
#73GIP AGONIST COMPOUNDS AND METHODS
#74CONJUGATED HEPCIDIN MIMETICS
#75ADIPONECTIN GLYCOPEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF
#76MODIFIED B-TYPE NATRIURETIC PEPTIDE
#77Self-replicating RNA and uses thereof
#78GIP DERIVATIVES AND USES THEREOF
#79BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#80Hepcidin analogues and uses thereof
#81COMPOSITIONS COMPRISING RELAXIN AND METHODS OF USE THEREOF
#82Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use
#83BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS
#84HAManalogues with improved amylin receptor (hAMY3R) potency
#85POLYPEPTIDES AND USES THEREOF
#86MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERINE ONCOPROTECTION, AND OVARIAN RESERVE AND UTERINE PRESERVATION
#87CONJUGATED HEPCIDIN MIMETICS
#88COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE
#89SCG2 NEUROPEPTIDES AND USES THEREOF
#90Enhanced immunogenicity for GPI-anchored antigens
#91CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS
#92AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS
#93METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN
#94GIP DERIVATIVE, LONG-ACTING CONJUGATE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#95INTER-APPLICATION WORKFLOW PERFORMANCE ANALYTICS
#96ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS
#97PEPTIDE, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#98MIRAC PROTEINS
#99Co-agonists of the GLP-1 and amylin receptors
#100METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#101RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN
#102RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN
#103COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS
#104Conjugated Hepcidin Mimetics
#105Targeting anabolic drugs for accelerated fracture repair
#106METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#107METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#108METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#109METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#110METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#111METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#112Novel Adrenomedullin Analog, Method for Producing the Same, and Pharmaceutical Use Thereof
#113Use of Human Resistin as a Trimerization Partner for Expression of Trimeric Proteins
#114METABOLICALLY STABLE PEPTIDE ANALOGS
#115ENGINEERED OPTIMIZED CYTOKINE COMPOSITIONS
#116COMPOSITION FOR PREVENTION OR TREATMENT OF HYPERLIPIDEMIA COMPRISING TRIGONAL GLUCAGON/GLP-1/GIP RECEPTOR AGONIST OR CONJUGATE THEREOF AND METHOD USING THE SAME
#117Long-acting adrenomedullin derivative
#118RAS INHIBITORY PEPTIDES AND USES THEREOF
#119SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES
#120ANTI-PACAP ANTIBODIES AND USES THEREOF
#121Long-Acting Adrenomedullin Derivatives
#122ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
#123PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS
#124INCRETIN ANALOGS AND USES THEREOF
#125Translatable molecules and synthesis thereof
#126NOVEL PEPTIDE HORMONES
#127Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides
#128Mucoadhesive microorganism
#129THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES
#130ANTI-MULLERIAN HORMONE POLYPEPTIDES
#131ERYTHROPOIETIN COMPOSITIONS AND METHODS OF USE
#132PRODUCTION OF GLYCOPROTEINS USING MANGANESE
#133MODIFIED IMMUNE CELL AND USE THEREOF
#134NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION
#135CONJUGATED HEPCIDIN MIMETICS
#136IMMUNE CHECKPOINT BLOCKING BISPECIFIC MOLECULES
#137Hepcidin analogues and uses thereof
#138Pharmaceutical preparation comprising recombinant HCG
#139SUPERAGONIST POLYPEPTIDE ANALOGS OF ADRENOMEDULLIN AND INTERMEDIN PEPTIDE HORMONES
#140Peptide analogs
#141USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
#142Long acting amylin receptor agonists and uses thereof
#143Biotechnology for curing hypothyroidism
#144SATIATION PEPTIDES FOR WEIGHT LOSS AND ALTERED TASTE SENSITIVITY
#145CLSP DERIVATIVE INCAPABLE OF BEING AFFECTED BY CLSP INHIBITING SUBSTANCE, AND CLSP ACTIVITY ENHANCING/PROTECTING AGENT
#146METHOD FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTEIN HORMONES
#147APPETITE SUPPRESSING COMPOUNDS
#148IDENTIFICATION OF A NEW POLYPEPTIDE HORMONE FOR MAINTENANCE OF OPTIMAL BODY WEIGHT AND BLOOD GLUCOSE
#149METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS
#150MONOMERIC PEPTIDE MULTI-AGONIST TARGETING THE GLP1 RECEPTOR AND NPY RECEPTORS
#151POLYPEPTIDES AND USES THEREOF
#152METHODS FOR THE FRACTIONATION OF PROTEINS
#153Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#154Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof
#155METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#156RECOMBINANT IRISIN GENE OPTIMIZED FOR EXPRESSION IN PLANTS AND METHOD FOR PRODUCING RECOMBINANT IRISIN PROTEIN USING SAME
#157ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO
#158COMPOSITION COMPRISING A POLYMERIC REAGENT
#159GIP receptor agonist peptide compounds and uses thereof
#160Derivatisation of Insulin with Polysaccharides
#161VARIANTS OF ERYTHROFERRONE AND THEIR USE
#162Acylated oxyntomodulin peptide analog
#163PEPTIDE TARGETING GIP AND GLP-2 RECEPTORS FOR TREATING BONE DISORDERS
#164METHODS, COMPOSITIONS AND USES THEREOF FOR REVERSING SACROPENIA
#165Methods, compositions and uses thereof for reversing sarcopenia
#166MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
#167SYSTEMS AND METHODS FOR COMPARTMENT SPATIAL ORGANIZATION
#168SOLUBLE NPY2 RECEPTOR AGONISTS
#169MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THEREOF FOR THE TREATMENT OF DISEASES
#170GIP agonist compounds and methods
#171RECOMBINANT ANTIBODY OF ANTI-HUMAN N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE
#172HUMAN RESISTIN COMPOSITIONS AND METHODS OF TREATING TLR4-MEDIATED DISEASE AND INFECTION
#173Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use
#174DUAL FUNCTION PROTEINS COMPRISING FGF21 MUTANT PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#175Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
#176Satiation peptide administration
#177METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES
#178Method for treating pulmonary hypertension with antibodies to human Resistin
#179Amylin analogues
#180In vivo protein N-acylation
#181ANTIBODY THAT BINDS MURINE WISE PROTEIN
#182Compounds for treatment of obesity
#183Peptide complex with immunodulatory and anti-inflammatory function
#184Method for purifying long chain polypeptide
#185TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#186STORAGE SOLUTION COMPOSITIONS FOR THE STABILIZATION OF PURIFIED MÜLLERIAN INHIBITING SUBSTANCE (MIS) AND METHODS OF USE AND PRODUCTION RELATED THERETO
#187Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#188Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
#189Reference standard for BNP measurement
#190PEPTIDE HORMONE WITH ONE OR MORE O-GLYCANS
#191Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#192BRAIN NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
#193Analogues of hepcidin mimetics with improved in vivo half lives
#194Radiation-Sterilized Biodegradable Drug Delivery Compositions
#195Self-assembling peptide for activating human mast cells
#196AMYLIN ANALOGUES
#197Long-acting adrenomedullin derivative conjugated with Fc region of immunoglobulin
#198Engineered Optimized Cytokine Compositions
#199Immunoglobulins and uses thereof
#200AMH-INH-GNIH tri-expression gene vaccine of improving fecundity of animals, preparation method and application
#201CARBOHYDRATE ESTERS AS INDUCERS FOR GENE EXPRESSION
#202Mucoadhesive microorganism
#203Diagnostic kit
#204CONJUGATED HEPCIDIN MIMETICS
#205SELECTION METHODS FOR GENETICALLY-MODIFIED T CELLS
#206ASPROSIN, A FAST-INDUCED GLUCOGENIC PROTEIN HORMONE
#207Production of Glycoproteins Using Manganese
#208METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY
#209Enhanced immunogenicity for GPI-anchored antigens
#210Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
#211ANGIOPOIETIN-LIKE PROTEIN 8 POLYPEPTIDE FRAGMENTS AND COMPOSITIONS THEREOF
#212Long-acting adrenomedullin derivative
#213Immunoglobulins and uses thereof
#214Engineered polypeptides having enhanced duration of action
#215Acylated oxyntomodulin peptide analog
#216Composition and Methods for Stimulating Gastrointestinal Motility
#217Peptide analogs
#218Compounds and methods for conjugation of biomolecules
#219KITS FOR DETECTION OF HEPCIDIN
#220METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#221BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS
#222Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#223LONG ACTING PROTEINS AND PEPTIDES AND METHODS OF MAKING AND USING THE SAME
#224Therapeutic agents comprising a BMP-9 peptide and eleastin-like peptides
#225Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
#226Pappalysin regulator
#227Combinatorial gene construct and non-viral delivery for anti-obesity
#228Pharmaceutical preparation comprising recombinant hCG
#229Apelin peptides and uses thereof
#230CYCLIC GALANIN-ANALOGS AND USES THEREOF
#231Ras inhibitory peptides and uses thereof
#232Amylin analogues
#233Humanized anti-PACAP antibodies
#234Humanized anti-PACAP antibodies
#235Humanized anti-PACAP antibodies
#236Human amylin analog polypeptides and methods of use
#237QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#238USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
#239Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation
#240In vivo protein N-acylation
#241Satiation peptide administration
#242HUMAN RESISTIN COMPOSITIONS AND METHODS OF TREATING TLR4-MEDIATED DISEASE AND INFECTION
#243ERFE FUSION POLYPEPTIDES COMPOSITIONS AND METHODS OF USE
#244Methods and pharmaceutical compositions for the treatment of kidney cancer
#245Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
#246Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising same
#247NPRA AGONISTS, COMPOSITIONS, AND USES THEREOF
#248HEPCIDIN AND MINI-HEPCIDIN ANALOGUES AND USES THEROF
#249Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substance
#250Protein and protein conjugate for diabetes treatment, and applications thereof
#251METHODS FOR MODULATING PRODUCTION PROFILES OF RECOMBINANT PROTEINS
#252METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#253Antibodies recognizing genetic variants of NT-proBNP
#254GIP derivatives and uses thereof
#255Immunoglobulins and uses thereof
#256Proteolically resistant cyclotides with angiotensin 1-7 like activity
#257USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#258Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#259METABOLICALLY STABLE PEPTIDE ANALOGS
#260Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
#261Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins
#262Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#263Conditionally Active Biological Proteins
#264Compositions comprising relaxin and methods of use thereof
#265METHODS FOR STIMULATION OF APPETITE AND INCREASE IN WEIGHT BY ADMINISTRATION OF ASPROSIN
#266Immunoglobulins and uses thereof
#267Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides
#268GIP agonist compounds and methods
#269Composition and Methods for Stimulating Gastrointestinal Motility
#270Anti-PACAP antibodies and uses thereof
#271PAC1 antibodies and uses thereof
#272ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#273Compositions and methods for brown fat induction and activity using FNDC5
#274Derivatisation of Insulin with Polysaccharides
#275ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
#276Modified proteins and methods of use thereof
#277Serum albumin binding molecules
#278Peptide compound
#279Antibodies to TTR and methods of use
#280Mucoadhesive microorganism
#281SOLID PHASE PEPTIDE SYNTHESIS
#282Method for promoting bone growth using activin-actriia antagonists
#283Hepcidin analogues and uses thereof
#284Hepcidin analogues and uses thereof
#285Cortistatin analogues and syntheses and uses thereof
#286Long-acting peptide analogs
#287ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO
#288Fusion protein comprising apelin and an anti-APLNR antibody
#289ANGIOPOIETIN-LIKE PROTEIN 8 (ANGPTL8)
#290Amino diacids containing peptide modifiers
#291Methods to Treat Diseases with Protein, Peptide and Antigen Modification
#292Method for preventing or treating heart failure by administering a medicament containing an antagonist of corticotropin releasing hormone receptor 2 (CRHR2)
#293PEPTIDE ANALOGS
#294METABOLICALLY STABLE SPEXIN PEPTIDE ANALOGS
#295GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS
#296COMPOSITION COMPRISING AN AB6 FAMILY DESIGNER LIGAND OF TGF-BETA SUPERFAMILY FOR TREATING LIVER DISEASE AND USE THEREOF
#297AMYLIN ANALOGUES
#298GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases, hyperlipemia and arteriosclerosis
#299Methods of increasing nutrient absorption in the intestine using therapeutic agents comprising GLP-2 and elastin-like peptides
#300FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME